Drugs / MER4101
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02500680 | Jul 2015 → Dec 2020 | influenza | Nova Immunotherapeutics Limited | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MER4101 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02500680 ↗ |
| Modality | Vaccine | “MAS-1-Adjuvanted Seasonal Inactivated Influenza Vaccine (MER4101)” NCT02500680 ↗ |